Nerve degeneration is prevented by a single intraneural apotransferrin injection into colchicine-injured sciatic nerves in the rat

Brain Research

Volumn 1117, Issue 1, 2006, Pages 80-91

  Aquino, Jorge B ^a   Musolino, Patricia L ^a   Coronel, M Florencia ^a   Villar, Marcelo J ^a   Setton Avruj, C Patricia ^b  

^a UNIVERSIDAD AUSTRAL   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

III tubulin, sciatic nerve; Cytoskeleton; Myelin basic protein; Wallerian degeneration

Indexed keywords

APOTRANSFERRIN; BETA TUBULIN; COLCHICINE; GENE PRODUCT; MYELIN BASIC PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOW; CONTROLLED STUDY; CYTOTOXICITY; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; NECROSIS; NERVE DEGENERATION; NERVE FIBER; NERVE FIBER TRANSPORT; NERVE INJURY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; SCIATIC NERVE; SURVIVAL;

ANIMALS; APOPROTEINS; AXONAL TRANSPORT; AXONS; COLCHICINE; CYTOSKELETON; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; IMMUNOHISTOCHEMISTRY; MICROTUBULES; MYELIN BASIC PROTEINS; MYELIN SHEATH; NERVE TISSUE PROTEINS; NEUROPROTECTIVE AGENTS; NEUROTOXINS; RATS; RATS, WISTAR; SCIATIC NEUROPATHY; TRANSFERRIN; TREATMENT OUTCOME; TUBULIN; UBIQUITIN THIOLESTERASE; WALLERIAN DEGENERATION;

WALLERIA;

EID: 33750130934     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.02.045     Document Type: Article

References (56)

1. Amos L.A. Microtubule structure and its stabilization. Org. Biomol. Chem. 2 (2004) 2153-2160
2. Angevine Jr. J.B. Nerve destruction by colchicine in mice and golden hamsters. J. Exp. Zool. 136 (1957) 363-391
3. Avellino A.M., Hart D., Dailey A.T., MacKinnon M., Ellegala D., and Kliot M. Differential macrophage responses in the peripheral and central nervous system during Wallerian degeneration of axons. Exp. Neurol. 136 (1995) 183-198
4. Banik N.L. Pathogenesis of myelin breakdown in demyelinating diseases: role of proteolytic enzymes. Crit. Rev. Neurobiol. 6 (1992) 257-271
5. Beuche W., and Friede R.L. The role of non-resident cells in Wallerian degeneration. J. Neurocytol. 13 (1984) 767-796
6. Brück W. The role of macrophages in Wallerian degeneration. Brain Pathol. 7 (1997) 741-752
7. Buss A., and Schwab M.E. Sequential loss of myelin proteins during Wallerian degeneration in the rat spinal cord. Glia 42 (2003) 424-432
8. Chaudhry V., Glass J.D., and Griffin J.W. Wallerian degeneration in peripheral nerve disease. Neurol. Clin. 10 (1992) 613-627
9. Chauvenet A.R., Shashi V., Selsky C., Morgan E., Kurtzberg J., Bell B., and Pediatric Oncology Group Study. Vincristine-induced neuropathy as the initial presentation of Charcot-Marie-Tooth disease in acute lymphoblastic leukemia: a Pediatric Oncology Group study. J. Pediatr. Hematol. Oncol. 25 (2003) 316-320
10. Cliffer K.D., Siuciak J.A., Carson S.R., Radley H.E., Park J.S., Lewis D.R., Zlotchenko E., Nguyen T., Garcia K., Tonra J.R., Stambler N., Cedarbaum J.M., Bodine S.C., Lindsay R.M., and DiStefano P.S. Physiological characterization of taxol-induced large-fiber sensory neuropathy in the rat. Ann. Neurol. 43 (1998) 46-55
11. Coleman M.P., and Perry V.H. Axon pathology in neurological disease: a neglected therapeutic target. Trends Neurosci. 25 (2002) 532-537
12. Coons A.H. Fluorescent antibody methods. In: Danielli J.F. (Ed). General Cytochemical Methods (1958), Academic Press, New York 399-422
13. Corfas G., Velardez M.O., Ko C.P., Ratner N., and Peles E. Mechanisms and roles of axon-Schwann cell interactions. J. Neurosci. 24 (2004) 9250-9260
14. Dailey A.T., Avellino A.M., Benthem L., Silver J., and Kliot M. Complement depletion reduces macrophage infiltration and activation during Wallerian degeneration and axonal regeneration. J. Neurosci. 18 (1998) 6713-6722
15. Escobar Cabrera O.E., Bongarzone E.R., Soto E.F., and Pasquíni J.M. Single intracerebral injection of apotransferrin in young rats induces increased myelination. Dev. Neurosci. 16 (1994) 248-254
16. Escobar Cabrera O.E., Zakin M.M., Soto E.F., and Pasquini J.M. Single intracranial injection of apotransferrin in young rats increases the expression of specific myelin protein mRNA. J. Neurosci. Res. 47 (1997) 603-608
17. Escobar Cabrera O.E., Bongiovanni G., Hallak M., Soto E.F., and Pasquíni J.M. The cytoskeletal components of the myelin fraction are affected by a single intracranial injection of apotransferrin in young rats. Neurochem. Res. 25 (2000) 669-676
18. Fernández-Valle C., Bunge R.P., and Bunge M.B. Schwann cells degrade myelin and proliferate in the absence of macrophages: evidence from in vitro studies of Wallerian degeneration. J. Neurocytol. 24 (1995) 667-679
19. Frei R., Motzing S., Kinkelin I., Schachner M., Koltzenburg M., and Martini R. Loss of distal axons and sensory Merkel cells and features indicative of muscle denervation in hindlimbs of P0-deficient mice. J. Neurosci. 19 (1999) 6058-6067
20. Garbern J.Y., Yool D.A., Moore G.J., Wilds I.B., Faulk M.W., Klugmann M., Nave K.A., Sistermans E.A., van der Knaap M.S., Bird T.D., Shy M.E., Kamholz J.A., and Griffiths I.R. Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation. Brain 125 (2002) 551-561
21. Geisert Jr. E.E., and Frankfurter A. The neuronal response to injury as visualized by immunostaining of class III beta-tubulin in the rat. Neurosci. Lett. 102 (1989) 137-141
22. George E.B., Glass J.D., and Griffin J.W. Axotomy-induced axonal degeneration is mediated by calcium influx through ion-specific channels. J. Neurosci. 15 (1995) 6445-6452
23. Ginn S.R., and Peterson G.M. Studies related to the use of colchicine as a neurotoxin in the septohippocampal cholinergic system. Brain Res. 590 (1992) 144-152
24. Glass J.D., Brushart T.M., George E.B., and Griffin J.W. Prolonged survival of transected nerve fibres in C57BL/Ola mice is an intrinsic characteristic of the axon. J. Neurocytol. 22 5 (1993) 311-321
25. Hirata K., Mitoma H., Ueno N., He J.W., and Kawabuchi M. Differential response of macrophage subpopulations to myelin degradation in the injured rat sciatic nerve. J. Neurocytol. 28 (1999) 685-695
26. Hoffman P.L., and Luduena R.F. Changes in the isotype composition of β-tubulin delivered to regenerating sensory axons by slow axonal transport. Brain Res. 742 (1996) 329-333
27. Ide C. Peripheral nerve regeneration. Neurosci. Res 25 (1996) 101-121
28. Jiang Y.Q., and Oblinger M.M. Differential regulation of beta III and other tubulin genes during peripheral and central neuron development. J. Cell Sci. 103 (1992) 643-651
29. Johnson G.D., and Nogueira Araujo G.M. A simple method of reducing the fading of immunofluorescence during microscopy. J. Immunol. Methods 43 (1981) 349-350
30. Kidd G., Andrews B., and Trapp B.D. Axons regulate distribution of Schwann cell microtubules. J. Neurosci. 16 (1996) 946-954
31. Kiffmeyer W.R., Tomusk E.V., and Mescher A.L. Axonal transport and release of transferrin in nerves of regenerating amphibian limbs. Dev. Biol. 147 (1991) 392-402
32. Kuncl R.W., and George E.B. Toxic neuropathies and myopathies. Curr. Opin. Neurol. 6 (1993) 695-704
33. Li G.L., Farooque M., Holtz A., and Olsson Y. Expression of the ubiquitin carboxyl-terminal hydrolase PGP 9.5 in axons following spinal cord compression trauma. An immunohistochemical study in the rat. APMIS 105 (1997) 384-390
34. Lin H.H., Snyder B.S., and Connor J.R. Transferrin expression in myelinated and non-myelinated peripheral nerves. Brain Res. 526 (1990) 217-220
35. Liu H.M., Yang L.H., and Yang Y.J. Schwann cell properties: III. C-fos expression, bFGF production, phagocytosis and proliferation during Wallerian degeneration. J. Neuropathol. Exp. Neurol. 54 (1995) 487-496
36. Marta C.B., Ortiz E.H., Hallak M., Baron B., Guillou F., Zakin M.M., Soto E.F., and Pasquíni J.M. Changes in the expression of cytoskeletal proteins in the CNS of transferrin transgenic mice. Dev. Neurosci. 24 (2002) 242-251
37. Martínez A.M.B., and Canavarro S. Early myelin breakdown following sural nerve crush: a freeze-fracture study. Braz. J. Med. Biol. Res. 33 (2000) 1477-1482
38. Mescher A.L., and Kiffmeyer W.R. Axonal release of transferrin in peripheral nerves of axolotls during regeneration. Monogr. Dev. Biol. 23 (1992) 100-109
39. Mescher A.L., and Munaim S.I. Transferrin and the growth-promoting effect of nerves. Int. Rev. Cytol. 110 (1988) 1-26
40. III-tubulin protein during axonal regeneration. J. Neurosci. 15 (1995) 1545-1555
41. Oosthuyse B., Moons L., Storkebaum E., Beck H., Nuyens D., Brusselmans K., Van Dorpe J., Hellings P., Gorselink M., Heymans S., Theilmeier G., Dewerchin M., Laudenbach V., Vermylen P., Raat H., Acker T., Vleminckx V., Van Den Bosch L., Cashman N., Fujisawa H., Drost M.R., Sciot R., Bruyninckx F., Hicklin D.J., Ince C., Gressens P., Lupu F., Plate K.H., Robberecht W., Herbert J.M., Collen D., and Carmeliet P. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat. Genet. 28 (2001) 131-138
42. Pesini P., Kopp J., Wong H., Grant G., and Hökfelt T. An immunohistochemical marker for Wallerian degeneration of fibers in the central and peripheral nervous system. Brain Res. 828 (1999) 41-59
43. Platt J.L., and Michael A.F. Retardation of fading and enhancement of intensity of immunofluorescence by p-phenylenediamine. J. Histochem. Cyotchem. 31 (1983) 840-842
44. Quasthoff S., and Hartung H.P. Chemotherapy-induced peripheral neuropathy. J. Neurol. 249 (2002) 9-17
45. Ramón y Cajal S. Degeneration and Regeneration of the Nervous System vol. 1 (1928), Oxford Univ. Press, London, UK
46. Rana S.S., Giuliani M.J., Oddis C.V., and Lacomis D. Acute onset of colchicine myoneuropathy in cardiac transplant recipients: case studies of three patients. Clin. Neurol. Neurosurg. 99 (1997) 266-270
47. Salis C., Goedelmann C.J., Pasquini J.M., Soto E.F., and 49 C.P. Holotransferrin but not apotransferrin prevents Schwann cell de-differentiation in culture. Dev. Neurosci. 24 (2002) 214-221
48. Samsam M., Mi W., Wessig C., Zielasek J., Toyka K.V., 11 M.P., and Martini R. The Wlds mutation delays robust loss of motor and sensory axons in a genetic model for myelin-related axonopathy. J. Neurosci. 23 (2003) 2833-2839
49. 0 and myelin basic protein-like immunoreactivities following ligation of the sciatic nerve in the rat. Neurochem. Res. 27 (2002) 1293-1303
50. Singer M., and Steinberg M.C. Wallerian degeneration: a reevaluation based on transected and colchicine-poisoned nerves in the amphibian, Triturus. Am. J. Anat. 133 (1972) 51-83
51. Stoll G., and Müller H.W. Nerve injury, axonal degeneration and neural regeneration: basic insights. Brain Pathol. 9 (1999) 313-325
52. Stoll G., Griffin J.W., Li C.Y., and Trapp B.D. Wallerian degeneration in the peripheral nervous system: participation of both Schwann cells and macrophages in myelin degradation. J. Neurocytol. 18 (1989) 671-683
53. Wang M.S., Wu Y., Culver D.G., and Glass J.D. Pathogenesis of axonal degeneration: parallels between Wallerian degeneration and vincristine neuropathy. J. Neuropathol. Exp. Neurol. 59 (2000) 599-606
54. Wilkinson K.D., Lee K.M., Deshpande S., Duerksen-Hughes P., Boss J.M., and Pohl J. The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase. Science 246 (1989) 670-673
55. Wong J., and Oblinger M.M. A comparison of peripheral and central axotomy effects on neurofilament and tubulin gene expression in rat dorsal root neurons. J. Neurosci. 10 (1990) 2215-2223
56. Wu W., Toma J.G., Chan H., Smith R., and Miller F.D. Disruption of fast axonal transport in vivo leads to alterations in Schwann cell gene expression. Dev. Biol. 163 (1994) 423-439